News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
Crystal Pharmatech is Heading to DCAT Week 2025! Meet Our Leadership Team.
We're excited to be in New York City from March 17-20 for DCAT Week 2025! Our leadership team will be there to connect and discuss the latest in small molecule drug development and CMC strategies.
Alex Chen, Ph.D.
Co-founder & CEO
Robert Wenslow, Ph.D.
Co-founder & CBO
Yongqiang Li, Ph.D.
CEO of Canada CDMO BU (Candoo)
Derik McCarthy
Subject Matter Expert
Yan Li
Senior Director
When: March 17-20
Where: Hotel 48 Lex, Suite 904, 517 Lexington Ave, New York City, New York, USA
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
